Finance

Lists
Why is RKT up 2,09%?
Dive Deeper
RKT:LON
Reckitt Benckiser Group Plc
GBX 4 992,00
+2,09%
(+102,00) 1D
30 Sep., 16:39:15 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for RKT...
Open
GBX 4 910,00
High
GBX 5 096,00
Low
GBX 4 910,00
Mkt. cap
41,95 mjd
Avg. vol.
1,33 m
Volume
2,58 m
Dividend
4,33%
Quarterly dividend
GBX 54,10
Ex-dividend date
06 Aug. 2026
P/E ratio
11,28
52-wk high
GBX 6 514,00
52-wk low
GBX 3 664,00
EPS
GBX 4,43
Shares outstanding
633,94 m
No. of employees
36 k
Open
GBX 4 910,00
High
GBX 5 096,00
Low
GBX 4 910,00
Mkt. cap
41,95 mjd
Avg. vol.
1,33 m
Volume
2,58 m
Dividend
4,33%
Quarterly dividend
GBX 54,10
Ex-dividend date
06 Aug. 2026
P/E ratio
11,28
52-wk high
GBX 6 514,00
52-wk low
GBX 3 664,00
EPS
GBX 4,43
Shares outstanding
633,94 m
No. of employees
36 k
News stories
From web sources and news partners
Profile
Reckitt is a British multinational consumer goods company headquartered in Slough, United Kingdom. It manufactures health and hygiene products. Reckitt's brands include the antiseptic brand Dettol, the sore throat medicine Strepsils, the toilet cleaner Harpic, the hair removal brand Veet, the cold, flu, and cough relief brand Mucinex, the indigestion remedy Gaviscon, the pain relief medication Nurofen and other brands and products like: Durex, Lysol, Finish, and Vanish. The company was formed in 1999 by the merger of British company Reckitt & Colman plc and Dutch company Benckiser N.V. Following the merger, the company was known as Reckitt Benckiser until 2021. Wikipedia
About Reckitt Benckiser Group Plc
CEOKris Licht
Employees36,2 k
Founded06 Jun. 2007
HeadquartersSlough, Berkshire, Verenigde Koninkryk
SectorHousehold goods
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,61 mjd
3,61 mjd
3,21 mjd
3,21 mjd
Cost of goods sold
1,42 mjd
1,42 mjd
1,33 mjd
1,33 mjd
Cost of revenue
1,42 mjd
1,42 mjd
1,33 mjd
1,33 mjd
Research and development expenses
158,00 m
158,00 m
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,07 mjd
1,07 mjd
1,26 mjd
1,26 mjd
Operating expense
1,22 mjd
1,22 mjd
1,29 mjd
1,29 mjd
Total operating expenses
2,65 mjd
2,65 mjd
2,62 mjd
2,62 mjd
Operating income
963,50 m
963,50 m
583,00 m
583,00 m
Other non operating income
-2,00 m
-2,00 m
-
-
EBT including unusual items
1,26 mjd
1,26 mjd
490,50 m
490,50 m
EBT excluding unusual items
865,00 m
865,00 m
490,50 m
490,50 m
Income tax expense
143,50 m
143,50 m
162,00 m
162,00 m
Effective tax rate
11,37%
11,37%
33,03%
33,03%
Other operating expenses
-1,00 m
-1,00 m
-
-
Net income
1,11 mjd
1,11 mjd
326,00 m
326,00 m
Net profit margin
30,79%
30,79%
10,17%
10,17%
Earnings per share
-
-
-
-
Interest and investment income
8,50 m
8,50 m
30,00 m
30,00 m
Interest expense
-107,50 m
-107,50 m
-111,00 m
-111,00 m
Net interest expenses
-99,00 m
-99,00 m
-81,00 m
-81,00 m
Depreciation and amortization charges
-6,00 m
-6,00 m
-
-
EBITDA
1,02 mjd
1,02 mjd
778,50 m
778,50 m
Gain or loss from assets sale
-622,00 m
-622,00 m
-14,50 m
-14,50 m
AI content may include mistakes. Learn more
Google-programme